Search filters

List of works by Orazio Caffo

2-weekly docetaxel: issues for clinical practice.

scientific article published on January 2015

A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.

scientific article published on December 2004

A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer

scientific article published on 21 July 2011

Aberrations of DNA Repair Pathways in Prostate Cancer: Future Implications for Clinical Practice?

scientific article published on 05 September 2018

Abiraterone acetate and its use in the treatment of metastatic prostate cancer: a review

scientific article published on 19 January 2018

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

scientific article published on 19 March 2019

Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials

scientific article published on 09 September 2019

Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?

scientific article published on 27 September 2014

Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer

scientific article

Association among metabolic syndrome, inflammation, and survival in prostate cancer

scientific article published on 02 March 2018

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

scientific article published on 26 February 2016

Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up

scientific article published on 01 February 1998

Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

scientific article published on 01 November 1996

Biochemical and objective response to abiraterone acetate withdrawal: incidence and clinical relevance of a new scenario for castration-resistant prostate cancer

scientific article published on 31 August 2013

Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario.

scientific article published on December 2012

Cardiovascular toxicities of systemic treatments of prostate cancer.

scientific article published on 24 January 2017

Cardiovascular toxicities of systemic treatments of prostate cancer: is oestrogen to the rescue?

scientific article published on 08 August 2017

Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.

scientific article published on 12 October 2011

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

scientific article published on 25 October 2014

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger

scientific article published on 20 April 2015

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

scientific article

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database

scientific article published on 29 November 2019

Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy

scientific article published on 01 September 1996

Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer

scientific article published on 01 April 2000

Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.

scientific article

Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.

scientific article published on 25 October 2012

Could Steroidal Abiraterone Metabolites Possibly Explain Abiraterone Withdrawal Syndrome?

scientific article

Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression

scientific article published on 01 April 1997

De novo metastatic castration sensitive prostate cancer: State of art and future perspectives

scientific article published on 11 August 2018

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience.

scientific article published on 20 August 2008

Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer.

scientific article published on 29 December 2014

Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.

scientific article published on 15 May 2008

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

scientific article published on 12 July 2019

Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer.

scientific article published on 7 April 2018

Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.

scientific article published on 28 April 2017

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program

article

Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone.

scientific article

Evaluation of sexual life after orchidectomy followed by radiotherapy for early-stage seminoma of the testis

scientific article published on 01 March 1999

Evaluation of toxicity and quality of life using a diary card during postoperative radiotherapy for rectal cancer

scientific article published on 01 April 2002

Feasibility of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer and atrial fibrillation

scientific article published on 21 February 2016

First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study.

scientific article published on 29 December 2016

Frequency of brain metastases from prostate cancer: an 18-year single-institution experience ⬇️

scientific article published on October 25, 2012

Gastrointestinal metastases from prostate cancer: a review of the literature.

scientific article

Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies.

scientific article

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

scientific article published in August 2003

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

scientific article published on 22 June 2020

Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial.

scientific article published on 26 May 2011

Impact of enzalutamide administration on primary prostate cancer volume: a metabolic evaluation by choline positron emission tomography in castration-resistant prostate cancer patients.

scientific article published on 15 March 2014

Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study.

scientific article published on 10 June 2015

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

scientific article published on 5 October 2015

Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.

scientific article published on March 2015

Is it possible that one patient may again experience a response to abiraterone acetate withdrawal during an abiraterone acetate rechallenge?

scientific article published on 24 March 2014

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

scientific article published on 20 April 2017

Long-term cosmetic outcome and toxicity in patients treated with quadrantectomy and radiation therapy for early-stage breast cancer.

scientific article

Management of brain metastases from lung cancer in the era of immunotherapy: a review of the literature

scientific article published on 06 January 2021

Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel

scientific article

Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.

scientific article published on 15 May 2015

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions.

scientific article published on 22 December 2016

Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document

scientific article published on 01 December 2019

Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients

scientific article published on 30 April 2020

Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.

scientific article published on August 2010

Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer.

scientific article

Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda

scientific article published on 05 July 2018

Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: assessment of clinical outcomes and predictive factors

scientific article published on 01 March 2012

Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?

scientific article published on January 2016

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

scientific article

Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: Results from a phase II study ⬇️

scientific article published on July 31, 2011

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.

scientific article

Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer.

scientific article published on 6 February 2010

Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.

scientific article

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.

scientific article

Physical side effects and quality of life during postoperative radiotherapy for uterine cancer. Prospective evaluation by a diary card.

scientific article published in March 2003

Potential value of rapid prostate-specific antigen decline in identifying primary resistance to abiraterone acetate and enzalutamide.

scientific article published on May 2014

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.

scientific article published on 19 May 2016

Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study.

scientific article

Quality of life after radiotherapy for early-stage testicular seminoma.

scientific article

Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation.

scientific article

Radiosensitization with chemotherapeutic agents.

scientific article

Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

scientific article published on 17 December 2018

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

scientific article published on 30 December 2019

Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment

scientific article

Reply to Kevin Lu's Letter to the Editor re: Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al. Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second

scientific article published on 28 August 2015

Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region

scientific article published on 26 October 2018

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

scientific article published on 6 August 2015

Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme

article

Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer

scientific article published on August 2015

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

scientific article published on 08 June 2018

Sequencing strategies in the new treatment landscape of prostate cancer

scientific article published on 19 August 2019

Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.

scientific article

Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 27 September 2019

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

scientific article published on 13 October 2016

Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy

scientific article published on 01 September 1997

Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis.

scientific article published on 2 February 2018

The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer

scientific article published on 6 September 2017

The prognostic value of pain in castration-sensitive prostate cancer

scientific article published on 10 July 2020

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era

scientific article published on 07 January 2019

Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up

scientific article

Treatment sequencing in oncology: balancing clinical trial and real-world evidence

scientific article published on 01 September 2019

Treatment with combined dabrafenib and trametinib in BRAFV600E-mutated metastatic malignant melanoma: a case of long-term complete response after treatment cessation.

scientific article published on 15 February 2018

Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature.

scientific article published on 22 October 2012

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

scientific article published on October 1994

Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.

scientific article

c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study

scientific article published on 01 January 1994

p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations

scientific article published on 01 December 1999

p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment

article

p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up

scientific article published on 01 May 2000

Paulina is supported by:

About Paulina

Help